En español
NIDA

National Advisory Council Agenda

129th Meeting of the National Advisory Council on Drug Abuse

Neuroscience Center - Conference Rooms C & D
6001 Executive Boulevard, Bethesda, MD.

Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event, should contact Christine Salaita via email or phone at 301-827-5843 or through the Federal Relay (1-800-877-8339). Requests should be made at least five days in advance of the workshop.

CRAN Joint Council Meeting Agenda

May 15, 2018

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c} and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).

9:00 a.m.

Call to Order
Nora Volkow, M.D. Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA

9:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Division of Therapeutics and Medical Consequences (DTMC)
Ivan Montoya, M.P.H., M.D., Deputy Director

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

10:15 a.m. Break

WebEx Information (Open Session Only)

Date and Time: Tuesday, May 15, 2018 - 10:30 a.m. Eastern Daylight Time (New York, GMT-04:00), 7 hours
Meeting Number (Access Code):  620 505 854
Password: Success1

When it's timejoin the meeting.

Join by phone:
1-650-479-3208 Call-in toll number (US/Canada)

Global call-in numbers

Can't join the meeting?
https://collaborationhelp.cisco.com/article/en-us/njmhfgbb

Important Notice:  Please note that this WebEx service allows audio and other information sent during the session to be recorded, which may be discoverable in a legal matter. By joining this session, you automatically consent to such recordings. If you do not consent to being recorded, discuss your concerns with the host or do not join the session.​

Open Session

10:30 a.m. Welcome and Opening Remarks
Nora Volkow, M.D. Director, NIDA
10:45 a.m. Director's Report
Nora Volkow, M.D. Director, NIDA
11:45 a.m. Discussion
Council Members
12:15 p.m. Lunch Break
1:15 p.m. Enhancing Partnerships Between the National Institute on Minority Health and Health Disparities (NIMHD) and NIDA
Eliseo Pérez-Stable, M.D., Director, NIMHD
1:55 p.m. The Concept of Patient Centricity and NIDA Research 
Elena Koustova, Ph.D., M.B.A., Director, Office of Translational Initiatives and Program Innovations, NIDA
2:30 p.m. Concept Clearances​
NIDA Staff
2:50 p.m. Public Comments
3:00 p.m. Adjourn

This page was last updated April 2018